CTRI/2015/07/005971已完成4 期
To evaluate efficacy, safety and tolerability of enzymatic formulation of amoxicillin + clavulanic acid (400mg/57mg) oral suspension compared to conventional amoxicillin + clavulanic acid (400mg/57mg) oral suspension for 7 days in treatment of upper respiratory tract infections in Indian patients.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •Pediatric Patients aged between 2 to 7 years of age with upper respiratory tract infections like acute otitis media or tonsillitis or sinusitis
排除标准
- •ii.Subjects requiring hospitalization
- •iii.Subjects with known or suspected hypersensitivity to penicillins
- •iv.Subjects who have received antimicrobial therapy within 7 days prior to enrollment.
- •v.Patient who severe complications of RTI.
- •vi.Critically ill patients
研究者
相似试验
进行中（未招募）
不适用
Evaluating the efficacy, safety, tolerability of use and treatment adherence in two different dosing schedules, pre-costagionale and costagionale, of a sublingual allergoid (Lais Parietaria)administered to patients suffered from oculorhinitis with or without bronchial asthma by Parietaria. Randomized double-blind, multicenter, parallel group, placebo-controlled. - ParLais/09Subjects with Parietaria pollen allergy.MedDRA version: 9.1Level: LLTClassification code 10039776Term: Seasonal allergic rhinitisEUCTR2008-007657-12-ITOFARMA
尚未招募
Unknown
Ketogenic diet therapy for chronic migrainesNeurological - Other neurological disordersMigraineACTRN12624000784516Alfred Health25
已完成
4 期
A clinical trial to study the effect of a Under eye Skin cream containing Biophytex LS 8740 and Proteasyl TP LS 8657 in patients with under eye dark circles.CTRI/2010/091/001346Glenmark Pharmaceutical limited500
已完成
4 期
A clinical trial to assess the efficacy, safety and tolerability of tigecycline in adult hospitalized patients with community acquired pneumonia (CAP).CTRI/2010/091/001439Glenmark Pharmaceuticals Limited120
进行中（未招募）
不适用
Evaluation of efficacy, safety and tolerability of an ADd-on therapy with Cianocabalamine Vitamin B12 plus Calcium levofolinate in relapsing-remitting multiple sclerosis patients Already in treatment with Nterferon beta over a period of 24 months for a better lonterm outComE - ADVANCEMULTIPLE SCLEROSISEUCTR2005-006071-12-ITAZIENDA OSPEDALIERA SAN CAMILLO FORLANINI276